metricas
covid
Annals of Hepatology EARLY IDENTIFICATION OF LIVER TRANSPLANTATION REQUIREMENT IN ALCOHOL-ASSOCIATED ...
Journal Information
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
#94
Full text access
EARLY IDENTIFICATION OF LIVER TRANSPLANTATION REQUIREMENT IN ALCOHOL-ASSOCIATED HEPATITIS
Visits
202
Luis Antonio Díaz Piga1, Francisco Idalsoaga2, Gene Im3, Bastián Alcayaga4, Muzzafar Haque5, Stephanie Rutledge3, Hanna Blaney6, Pojsakorn Danpanichkul7, Arun Valsan8, Gowripriya Nair8, Gustavo Ayares9, Renata Farias9, Jorge Arnold9, Pedro Acuña9, Kaanthi Rama10, Carlos Esteban Coronel-Castillo11, Carolina Ramírez Cádiz12, Vinay Jahagirdar10, Winston Dunn13, Heer Mehta13..., María Poca14, German Soriano14, Berta Cuyàs14, Joaquín Cabezas15, Victor Echavarría15, Meritxell Ventura-Cots16, Juan G. Abraldes17, Mustafa Al-Karaghouli17, Lubomir Skladaný18, Daniel J. Havaj18, Karolina Sulejova18, Svetlana Adamcova Selcanova18, Prasun K. Jalal19, Mohamed A. Elfeki20, Mohamad Ali Ibrahim21, Katherine Maldonado22, Juan Pablo Roblero23, Daniela Simian24, José Antonio Velarde-Ruiz25, Jacqueline Córdova-Gallardo26, Fátima Higuera de la Tijera11, Rita Silva27, Cristina Melo Rocha28, Roberta Araujo29, Gustavo Henrique Pereira30, Fernando Bessone31, Mario Tanno31, Ayelen Kisch32, Manuel Mendizabal33, Sebastián Marciano34, Gonzalo Gomez Perdiguero34, Pedro Montes35, Patricia Guerra Salazar36, Geraldine Ramos36, Enrique Carrera Estupiñan37, Kristina R. Chacko38, Nyingi Kemmer39, Saurabh Agrawal39, Luciana Lofego Goncalves40, Oluwatosin Oguntoye41, Douglas Simonetto42, Arun J. Sanyal10, Rohit Loomba1, Vijay Shah42, Ashwani K. Singal21, Patrick Kamath42, Marco Arrese Jiménez2, Ramon Bataller43, Juan Pablo Arab10Ver más
1 MASLD Research Center. Division of Gastroenterology and Hepatology. University of California San Diego, USA.
2 Departmento de Gastroenterología. Escuela de Medicina. Pontificia Universidad Católica de Chile.
3 Center for Liver Disease and Transplantation. Columbia University Vagelos College of Physicians and Surgeons, USA.
4 Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de Chile.
5 Department of Internal Medicine. College of Medicine. University of Saskatchewan, Canada.
6 MedStar Georgetown University Hospital. Medstar Transplant Hepatology Institute, USA.
7 Department of Internal Medicine. Texas Tech University Health Sciences Center, USA.
8 Department of Gastroenterology. Hepatology Division. Amrita Institute of Medical Sciences and Research Centre, India.
9 Departamento de Gastroenterología. Escuela de Medicina. Pontificia Universidad Católica de Chile.
10 Division of Gastroenterology. Hepatology. and Nutrition. Department of Internal Medicine. Virginia Commonwealth University School of Medicine, USA.
11 Departamento de Gastroenterología. Hospital General de México "Dr. Eduardo Liceaga".
12 Department of Anesthesiology. Virginia Commonwealth University School of Medicine, USA.
13 University of Kansas Medical Center, USA.
14 Hospital de la Santa Creu i Sant Pau, España.
15 University Hospital Marques de Valdecilla, España.
16 Liver Unit. Hospital Vall D’hebron. Universitat Autonoma Barcelona. Ciberehd, España.
17 University of Alberta, Canada.
18 Slovak Medical University. F. D. Roosevelt University Hospital, Slovak Republic.
19 Baylor College of Medicine, USA.
20 Department of Medicine. University of South Dakota Sanford School of Medicine.
21 Division of Gastroenterology. Hepatology and Nutrition. Department of Medicine. University of Louisville School of Medicine, USA.
22 Clínica de Gastroenterología y Endoscopia Digestiva Intera. Servicios de Salud Intera, Guatemala.
23 Hospital Clínico Universidad de Chile. Escuela de Medicina. Universidad de Chile.
24 Sección Gastroenterología, Chile.
25 Hospital Civil Guadalajara, México.
26 Hospital Juarez de México.
27 Unidade de Transplante de Figado e do Hospital de Base da Faculdade de Medicina de São Jose do Rio Preto, Brasil.
28 Fundação Hospital Adriano Jorge, Brasil.
29 Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Brasil.
30 Hospital Federal de Bonsucesso, Brasil.
31 Hospital Provincial del Centenario, Argentina.
32 Hospital de Gastroenterología “Dr. Carlos Bonorino Udaondo”, Argentina.
33 Hepatology and Liver Transplant Unit. Hospital Universitario Austral, Argentina.
34 Hospital Italiano Buenos Aires, Argentina.
35 Hospital Nacional Daniel A. Carrión, Peru.
36 Instituto Gastroenterológico Boliviano-Japonés, Bolivia.
37 Hospital Eugenio Espejo, Ecuador.
38 Montefiore Medical Center, USA.
39 Division of Gastroenterology. Tampa General Hospital, USA.
40 Serviço de Gastroenterologia. University Hospital-Federal University of Espirito Santo, Brasil.
41 Division of Gastroenterology. Federal Teaching Hospital Ido-Ekiti, Nigeria.
42 Mayo Clinic, USA.
43 Hospital Clinic, España.
Ver más
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 30. Issue S2

Abstracts of the 2025 Annual Meeting of the ALEH

More info
Introduction and Objectives

Severe alcohol‐associated hepatitis (AH) has a high risk of short-term mortality especially in those r with acute‐on‐chronic liver failure (ACLF). Delayed evaluation for liver transplantation (LT) in severe AH often worsens nutritional and functional status. This study aimed to identify early mortality predictors.

Materials and Methods

In a prospective study, 981 adults with AH were enrolled from 32 centers in 14 countries (January 2015–September 2024). ACLF was classified by EASL-CLIF criteria. Primary outcomes were 30- and 90-day mortality. Competing-risk regression (LT as the competing event) and receiver-operating-characteristic (AUROC) analyses evaluated clinical scores predicting development of ACLF grades 2–3 within seven days of admission.

Results

The mean age was 48.3 ± 11.2 years, and 88.7% were male. Within the first week, 68.8% of patients had ACLF—30.1% with grade 1, 34.5% with grade 2, and 35.4% with grade 3. Overall survival rates were 84.7% at 30 days and 75.8% at 90 days. Adjusted analyses identified increasing age, infections, higher admission MELD score, and ACLF grades 2 (subdistribution hazard ratio [sHR] 1.59) and 3 (sHR 2.58) as independent predictors of 90-day mortality. The MELD score was the best predictor of developing ACLF grades 2–3 (AUROC 0.869), with MELD ≥28 showing 64% sensitivity and 90% specificity. These findings were confirmed in two external validation cohorts: a prospectively enrolled U.S. cohort (n=234) and a retrospective cohort from seven countries (n=602).

Conclusions

ACLF and infections are key determinants of mortality in severe AH. The MELD score at admission is a robust early predictor of high‐grade ACLF, supporting its use to determine LT candidacy earlier.

Full Text

Conflict of interest: None

Figure: Comparison of the performance of different models in predicting the development of acute-on-chronic liver failure (ACLF) grade 2-3 during the first week of admission using the area under the Receiver Operating Characteristic (ROC) curves. Analysis included the Model of End-stage Liver Disease (MELD), the Maddrey’s discriminant function (mDF), and the Age-Bilirubin-International Normalized Ratio-Creatinine (ABIC) scores.

Download PDF
Article options
Tools